Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging
Aim:To determine in vivo whether the lateral geniculate nucleus (LGN) undergoes atrophy in patients with glaucoma and vision loss compared with normal subjects.Methods:Following institutional St Michael’s Hospital Research Ethics Board approval, a prospective and masked neuroimaging study was conduc...
Saved in:
Published in | British journal of ophthalmology Vol. 93; no. 1; pp. 56 - 60 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
BMA House, Tavistock Square, London, WC1H 9JR
BMJ Publishing Group Ltd
01.01.2009
BMJ Publishing Group BMJ Publishing Group LTD |
Subjects | |
Online Access | Get full text |
ISSN | 0007-1161 1468-2079 1468-2079 |
DOI | 10.1136/bjo.2008.138172 |
Cover
Summary: | Aim:To determine in vivo whether the lateral geniculate nucleus (LGN) undergoes atrophy in patients with glaucoma and vision loss compared with normal subjects.Methods:Following institutional St Michael’s Hospital Research Ethics Board approval, a prospective and masked neuroimaging study was conducted on glaucoma patients with visual-field defects affecting both eyes (n = 10) and age-matched controls (n = 8). Following informed consent, all subjects underwent 1.5-Tesla MRI. Coronal proton density magnetic resonance images of both LGNs were obtained, and LGN height measurements were measured by consensus by three neuroradiologists masked to the diagnosis. Glaucoma and control groups were compared using the t test.Results:Both LGNs were identified and visualised by 1.5-Tesla MRI for every subject. Compared with controls, the mean LGN heights in glaucoma were decreased in right (4.09 (0.89) mm vs 4.74 (0.54) mm, p>0.05) and left LGNs (3.98 (0.57) mm vs 4.83 (0.95) mm; p = 0.033). The combined right and left LGN height in glaucoma was significantly decreased compared with controls (8.07 (1.06) mm vs 9.56 (0.86) mm; p = 0.005).Conclusion:In vivo MRI evidence of LGN degeneration in human glaucoma is consistent with ex vivo primate and human neuropathological studies. LGN atrophy may be a relevant biomarker of visual system injury and/or progression in some glaucoma patients. |
---|---|
Bibliography: | href:bjophthalmol-93-56.pdf ark:/67375/NVC-MPBJBBXX-F PMID:18697810 local:bjophthalmol;93/1/56 istex:AB13F4C0241C57E1555F6A1EB6B0790A3CF973EA ArticleID:bj138172 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0007-1161 1468-2079 1468-2079 |
DOI: | 10.1136/bjo.2008.138172 |